Cas:84661-23-4 9-Chloro-2-methyl-5H-pyrazolo[1,5-d][1,4]benzodiazepin-6(7H)-one manufacturer & supplier

We serve Chemical Name:9-Chloro-2-methyl-5H-pyrazolo[1,5-d][1,4]benzodiazepin-6(7H)-one CAS:84661-23-4 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

9-Chloro-2-methyl-5H-pyrazolo[1,5-d][1,4]benzodiazepin-6(7H)-one

Chemical Name:9-Chloro-2-methyl-5H-pyrazolo[1,5-d][1,4]benzodiazepin-6(7H)-one
CAS.NO:84661-23-4
Synonyms:9-Chloro-2-methyl-5H-pyrazolo[1,5-d][1,4]benzodiazepin-6(7H)-one;5H-Pyrazolo[1,5-d][1,4]benzodiazepin-6(7H)-one, 9-chloro-2-methyl-;5h-pyrazolo[1,5-d][1,4]benzodiazepin-6(7h)-one,9-chloro-2-methyl-;erdosteine
Molecular Formula:C12H10ClN3O
Molecular Weight:247.680
HS Code:

Physical and Chemical Properties:
Melting point:286 ºC
Boiling point:509.8±40.0 °C at 760 mmHg
Density:1.5±0.1 g/cm3
Index of Refraction:1.718
PSA:46.92000
Exact Mass:247.051239
LogP:2.18

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 9-Chloro-2-methyl-5H-pyrazolo[1,5-d][1,4]benzodiazepin-6(7H)-one chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,erdosteine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,9-Chloro-2-methyl-5H-pyrazolo[1,5-d][1,4]benzodiazepin-6(7H)-one Use and application,5h-pyrazolo[1,5-d][1,4]benzodiazepin-6(7h)-one,9-chloro-2-methyl- technical grade,usp/ep/jp grade.


Related News: Zynteglo is a one-time treatment for a blood disorder known as beta thalassaemia in patients 12 years and older who require regular blood transfusions. 5-Fluorouridine manufacturers “The Delta variant is clearly circulating, and it’s more contagious, and it seems to be causing more disease,” said ACIP member Katherine Poehling, M.D., an epidemiologist at Wake Forest School of Medicine. 4-[(4-nitrophenyl)azo]benzene-1,3-diamine suppliers In 2021, the combo has raked in $818 million in the first half of the year alone for Novartis, a number that is already up 11% from last year. Comparatively, Roche reported $218 million in sales of Zelboraf in 2016, and revenue was not reported in its most recent mid-year update. 4-(dimethylamino)phenylacetic acid vendor & factory.